Literature DB >> 12154231

Restriction of lentivirus in monkeys.

Caroline Besnier1, Yasuhiro Takeuchi, Greg Towers.   

Abstract

Retroviruses are able to cross species barriers and have done so many times throughout evolution. Perhaps as a consequence, dominant mechanisms have arisen to block infection by murine retroviruses in mice (restriction factor Fv1) and humans (restriction factor Ref1), as well as in other mammals. Here we describe a block to HIV and simian immunodeficiency virus in monkeys. Like previously described restrictions the block is saturable and gives rise to multiple-hit infection kinetics. Furthermore, like restriction of murine leukemia virus in humans, the block is before reverse transcription. Intriguingly, African green monkey cells are able to block both HIV and simian immunodeficiency virus, and each virus is able to saturate and abrogate the restriction of the other, suggesting that a common factor is responsible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154231      PMCID: PMC129369          DOI: 10.1073/pnas.172384599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Characterization of Fv-1 host range strains of murine retroviruses by titration and p30 protein characteristics.

Authors:  R W Tennant; J A Otten; A Brown; W K Yang; S J Kennel
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

2.  Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection.

Authors:  B Chackerian; E M Long; P A Luciw; J Overbaugh
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.

Authors:  T Dorfman; H G Göttlinger
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Early replication block of human immunodeficiency virus type 1 in monkey cells.

Authors:  R Shibata; H Sakai; M Kawamura; K Tokunaga; A Adachi
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

5.  Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections.

Authors:  C S Tailor; Y Takeuchi; B O'Hara; S V Johann; R A Weiss; M K Collins
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  Fv-1 N- and B-tropism-specific sequences in murine leukemia virus and related endogenous proviral genomes.

Authors:  L R Boone; P L Glover; C L Innes; L A Niver; M C Bondurant; W K Yang
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

8.  Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  N Kaushik; N Rege; P N Yadav; S G Sarafianos; M J Modak; V N Pandey
Journal:  Biochemistry       Date:  1996-09-10       Impact factor: 3.162

9.  Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells.

Authors:  S Himathongkham; P A Luciw
Journal:  Virology       Date:  1996-05-15       Impact factor: 3.616

10.  Positional cloning of the mouse retrovirus restriction gene Fv1.

Authors:  S Best; P Le Tissier; G Towers; J P Stoye
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

View more
  167 in total

1.  Interaction of Moloney murine leukemia virus matrix protein with IQGAP.

Authors:  Juliana Leung; Andrew Yueh; Frank S K Appah; Bing Yuan; Kenia de los Santos; Stephen P Goff
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

2.  Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.

Authors:  Theodora Hatziioannou; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  An intracellular block to primate lentivirus replication.

Authors:  Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

4.  Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.

Authors:  Neeltje A Kootstra; Carsten Munk; Nina Tonnu; Nathaniel R Landau; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

5.  In defense of the cell: TRIM5alpha interception of mammalian retroviruses.

Authors:  Kyeongeun Lee; Vineet N KewalRamani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

6.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Authors:  Sébastien Nisole; Clare Lynch; Jonathan P Stoye; Melvyn W Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

8.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

9.  HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6.

Authors:  Kyeongeun Lee; Alok Mulky; Wendy Yuen; Thomas D Martin; Nicholas R Meyerson; Laura Choi; Hyun Yu; Sara L Sawyer; Vineet N Kewalramani
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

10.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.